Hypoglycemia
This medicine may lower blood sugar.
Medicine information HUMALOG BASAL KWIKPEN 100U / ml injection suspension
- Product code:
- W53876001
- Quantity:
- 5
- Pack volume:
- 3ml
- Indicated for:
- diabetes mellitus
- Route of administration:
- injectable
- Substance:
- insulin lispro (insulin)
- ATC
- A10AC04 — Alimentary tract and metabolism | Insulins and analogues | Insulins and analogues for injection, intermediate-acting
Insulin lispro is a rapid-acting insulin used to control blood sugar levels in people with type 1 and type 2 diabetes. It is an insulin analog, meaning its structure has been slightly modified compared to natural human insulin to act more quickly after administration. Insulin lispro is typically used before meals to manage rapid blood sugar spikes caused by food intake.
This insulin begins to work approximately 15 minutes after injection, reaches its peak effect in 30-90 minutes, and lasts about 3-5 hours. Due to its rapid action, insulin lispro is often used in combination with longer-acting or basal insulins to provide long-term blood sugar control.
While insulin lispro is effective, its use requires caution. The dose must be adjusted based on blood sugar levels, food intake, and physical activity. Hypoglycemia (excessively low blood sugar) is the most common side effect and can cause symptoms such as dizziness, sweating, trembling, or confusion. It is important for patients to always have a source of fast-acting sugar on hand to treat hypoglycemia.
Insulin lispro should be used as directed by a doctor, and patients should regularly monitor their blood sugar levels. Proper injection technique is essential, and injections should be avoided in areas with irritation or scarring. If severe side effects or difficulties in blood sugar control occur, immediate medical attention is necessary.
This insulin begins to work approximately 15 minutes after injection, reaches its peak effect in 30-90 minutes, and lasts about 3-5 hours. Due to its rapid action, insulin lispro is often used in combination with longer-acting or basal insulins to provide long-term blood sugar control.
While insulin lispro is effective, its use requires caution. The dose must be adjusted based on blood sugar levels, food intake, and physical activity. Hypoglycemia (excessively low blood sugar) is the most common side effect and can cause symptoms such as dizziness, sweating, trembling, or confusion. It is important for patients to always have a source of fast-acting sugar on hand to treat hypoglycemia.
Insulin lispro should be used as directed by a doctor, and patients should regularly monitor their blood sugar levels. Proper injection technique is essential, and injections should be avoided in areas with irritation or scarring. If severe side effects or difficulties in blood sugar control occur, immediate medical attention is necessary.
General data about HUMALOG BASAL KWIKPEN 100U / ml
- Substance:
- insulin lispro
- Date of latest medicines list:
- 01-10-2015
- Product code:
- W53876001
- Strength:
- 100U / ml
- Pharmaceutical form:
- injection suspension
- Pack volume:
- 3ml
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for insulin lispro
Strengths available for insulin lispro
- 100U/ml
- 100UI/ml
- 200 U/ml
- 200U/ml
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 25/08/2009
- Source record: last updated
- 13/07/2026
Warnings:
Electrolyte disturbances
This medicine may change blood electrolyte levels.